(Q58983536)
Statements
Comparative antiproliferative and cytotoxic profile of bevacizumab (Avastin), pegaptanib (Macugen) and ranibizumab (Lucentis) on different ocular cells (English)
Efdal Yoeruek
Ana Sierra
Barbara Wallenfels-Thilo
Ulrich Schraermeyer
Bernhard Spitzer
Peter Szurman
Martin S Spitzer
Karl U Bartz-Schmidt
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference